Global Bio-pharma Market Professional Survey Report 2016

December 2016 | 117 pages | ID: GB2B458C066EN
QYResearch

Abstracts

Notes:

Production, means the output of Bio-pharma

Revenue, means the sales value of Bio-pharma

This report studies Bio-pharma in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• F. Hoffmann-La Roche AG
• Johnson & Johnson Services
• Sanofi, Amgen
• AbbVie
• Merck & Co., Inc
• Biogen Idec
• Bayer AG
• Eli Lilly and Company
• Novartis AG GlaxoSmithKline Plc
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories

By types, the market can be split into

• Monoclonal Antibodies
• Recombinant Proteins
• Granulocyte-Colony Stimulating Factor (G-CSF)
• Interferons
• Recombinant Human Insulin
• Erythropoietin
• Vaccines
• Growth Hormones
• Purified Proteins
• Others

By Application, the market can be split into

• Metabolic Disorders
• Oncology
• Neurological Disorders
• Cardiovascular Diseases
• Inflammatory and Infectious Diseases
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

Contents

Global Bio-pharma Market Professional Survey Report 2016

1 INDUSTRY OVERVIEW OF BIO-PHARMA

1.1 Definition and Specifications of Bio-pharma
  1.1.1 Definition of Bio-pharma
  1.1.2 Specifications of Bio-pharma
1.2 Classification of Bio-pharma
  1.2.1 Monoclonal Antibodies
  1.2.2 Recombinant Proteins
  1.2.3 Granulocyte-Colony Stimulating Factor (G-CSF)
  1.2.4 Interferons
  1.2.5 Recombinant Human Insulin
  1.2.6 Erythropoietin
  1.2.7 Vaccines
  1.2.8 Growth Hormones
  1.2.9 Purified Proteins
  1.2.10 Others
1.3 Applications of Bio-pharma
  1.3.1 Metabolic Disorders
  1.3.2 Oncology
  1.3.3 Neurological Disorders
  1.3.4 Cardiovascular Diseases
  1.3.5 Inflammatory and Infectious Diseases
  1.3.6 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF BIO-PHARMA

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bio-pharma
2.3 Manufacturing Process Analysis of Bio-pharma
2.4 Industry Chain Structure of Bio-pharma

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF BIO-PHARMA

3.1 Capacity and Commercial Production Date of Global Bio-pharma Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Bio-pharma Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Bio-pharma Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Bio-pharma Major Manufacturers in 2015

4 GLOBAL BIO-PHARMA OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016E Global Bio-pharma Capacity and Growth Rate Analysis
  4.2.2 2015 Bio-pharma Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016E Global Bio-pharma Sales and Growth Rate Analysis
  4.3.2 2015 Bio-pharma Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016E Global Bio-pharma Sales Price
  4.4.2 2015 Bio-pharma Sales Price Analysis (Company Segment)

5 BIO-PHARMA REGIONAL MARKET ANALYSIS

5.1 North America Bio-pharma Market Analysis
  5.1.1 North America Bio-pharma Market Overview
  5.1.2 North America 2011-2016E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Bio-pharma Sales Price Analysis
  5.1.4 North America 2015 Bio-pharma Market Share Analysis
5.2 China Bio-pharma Market Analysis
  5.2.1 China Bio-pharma Market Overview
  5.2.2 China 2011-2016E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016E Bio-pharma Sales Price Analysis
  5.2.4 China 2015 Bio-pharma Market Share Analysis
5.3 Europe Bio-pharma Market Analysis
  5.3.1 Europe Bio-pharma Market Overview
  5.3.2 Europe 2011-2016E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016E Bio-pharma Sales Price Analysis
  5.3.4 Europe 2015 Bio-pharma Market Share Analysis
5.4 Southeast Asia Bio-pharma Market Analysis
  5.4.1 Southeast Asia Bio-pharma Market Overview
  5.4.2 Southeast Asia 2011-2016E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016E Bio-pharma Sales Price Analysis
  5.4.4 Southeast Asia 2015 Bio-pharma Market Share Analysis
5.5 Japan Bio-pharma Market Analysis
  5.5.1 Japan Bio-pharma Market Overview
  5.5.2 Japan 2011-2016E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016E Bio-pharma Sales Price Analysis
  5.5.4 Japan 2015 Bio-pharma Market Share Analysis
5.6 India Bio-pharma Market Analysis
  5.6.1 India Bio-pharma Market Overview
  5.6.2 India 2011-2016E Bio-pharma Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Bio-pharma Sales Price Analysis
  5.6.4 India 2015 Bio-pharma Market Share Analysis

6 GLOBAL 2011-2016E BIO-PHARMA SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Bio-pharma Sales by Type
6.2 Different Types of Bio-pharma Product Interview Price Analysis
6.3 Different Types of Bio-pharma Product Driving Factors Analysis
  6.3.1 Monoclonal Antibodies of Bio-pharma Growth Driving Factor Analysis
  6.3.2 Recombinant Proteins of Bio-pharma Growth Driving Factor Analysis
  6.3.3 Granulocyte-Colony Stimulating Factor (G-CSF) of Bio-pharma Growth Driving Factor Analysis
  6.3.4 Interferons of Bio-pharma Growth Driving Factor Analysis
  6.3.5 Recombinant Human Insulin of Bio-pharma Growth Driving Factor Analysis
  6.3.6 Erythropoietin of Bio-pharma Growth Driving Factor Analysis
  6.3.7 Vaccines of Bio-pharma Growth Driving Factor Analysis
  6.3.8 Growth Hormones of Bio-pharma Growth Driving Factor Analysis
  6.3.9 Purified Proteins of Bio-pharma Growth Driving Factor Analysis
  6.3.10 Others of Bio-pharma Growth Driving Factor Analysis

7 GLOBAL 2011-2016E BIO-PHARMA SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Bio-pharma Consumption by Application
7.2 Different Application of Bio-pharma Product Interview Price Analysis
7.3 Different Application of Bio-pharma Product Driving Factors Analysis
  7.3.1 Metabolic Disorders of Bio-pharma Growth Driving Factor Analysis
  7.3.2 Oncology of Bio-pharma Growth Driving Factor Analysis
  7.3.3 Neurological Disorders of Bio-pharma Growth Driving Factor Analysis
  7.3.4 Cardiovascular Diseases of Bio-pharma Growth Driving Factor Analysis
  7.3.5 Inflammatory and Infectious Diseases of Bio-pharma Growth Driving Factor Analysis
  7.3.6 Others of Bio-pharma Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF BIO-PHARMA

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 Pfizer 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2015 Bio-pharma Business Region Distribution Analysis
8.2 F. Hoffmann-La Roche AG
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 F. Hoffmann-La Roche AG 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 F. Hoffmann-La Roche AG 2015 Bio-pharma Business Region Distribution Analysis
8.3 Johnson & Johnson Services
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Johnson & Johnson Services 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Johnson & Johnson Services 2015 Bio-pharma Business Region Distribution Analysis
8.4 Sanofi, Amgen
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 Sanofi, Amgen 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Sanofi, Amgen 2015 Bio-pharma Business Region Distribution Analysis
8.5 AbbVie
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 AbbVie 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 AbbVie 2015 Bio-pharma Business Region Distribution Analysis
8.6 Merck & Co., Inc
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Merck & Co., Inc 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Merck & Co., Inc 2015 Bio-pharma Business Region Distribution Analysis
8.7 Biogen Idec
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 Biogen Idec 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Biogen Idec 2015 Bio-pharma Business Region Distribution Analysis
8.8 Bayer AG
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Bayer AG 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bayer AG 2015 Bio-pharma Business Region Distribution Analysis
8.9 Eli Lilly and Company
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 Eli Lilly and Company 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Eli Lilly and Company 2015 Bio-pharma Business Region Distribution Analysis
8.10 Novartis AG GlaxoSmithKline Plc
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Novartis AG GlaxoSmithKline Plc 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Novartis AG GlaxoSmithKline Plc 2015 Bio-pharma Business Region Distribution Analysis
8.11 Bristol-Myers Squibb Company
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
    8.11.2.1 Type I
    8.11.2.2 Type II
    8.11.2.3 Type III
  8.11.3 Bristol-Myers Squibb Company 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Bristol-Myers Squibb Company 2015 Bio-pharma Business Region Distribution Analysis
8.12 AstraZeneca PLC
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
    8.12.2.1 Type I
    8.12.2.2 Type II
    8.12.2.3 Type III
  8.12.3 AstraZeneca PLC 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 AstraZeneca PLC 2015 Bio-pharma Business Region Distribution Analysis
8.13 Abbott Laboratories
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
    8.13.2.1 Type I
    8.13.2.2 Type II
    8.13.2.3 Type III
  8.13.3 Abbott Laboratories 2015 Bio-pharma Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 Abbott Laboratories 2015 Bio-pharma Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF BIO-PHARMA MARKET

9.1 Global Bio-pharma Market Trend Analysis
  9.1.1 Global 2016-2021 Bio-pharma Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Bio-pharma Sales Price Forecast
9.2 Bio-pharma Regional Market Trend
  9.2.1 North America 2016-2021 Bio-pharma Consumption Forecast
  9.2.2 China 2016-2021 Bio-pharma Consumption Forecast
  9.2.3 Europe 2016-2021 Bio-pharma Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Bio-pharma Consumption Forecast
  9.2.5 Japan 2016-2021 Bio-pharma Consumption Forecast
  9.2.6 India 2016-2021 Bio-pharma Consumption Forecast
9.3 Bio-pharma Market Trend (Product Type)
9.4 Bio-pharma Market Trend (Application)

10 BIO-PHARMA MARKETING TYPE ANALYSIS

10.1 Bio-pharma Regional Marketing Type Analysis
10.2 Bio-pharma International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Bio-pharma by Regions
10.4 Bio-pharma Supply Chain Analysis

11 CONSUMERS ANALYSIS OF BIO-PHARMA

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL BIO-PHARMA MARKET PROFESSIONAL SURVEY REPORT 2016

Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bio-pharma
Table Product Specifications of Bio-pharma
Table Classification of Bio-pharma
Figure Global Production Market Share of Bio-pharma by Type in 2015
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Recombinant Proteins Picture
Table Major Manufacturers of Recombinant Proteins
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Picture
Table Major Manufacturers of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure Interferons Picture
Table Major Manufacturers of Interferons
Figure Recombinant Human Insulin Picture
Table Major Manufacturers of Recombinant Human Insulin
Figure Erythropoietin Picture
Table Major Manufacturers of Erythropoietin
Figure Vaccines Picture
Table Major Manufacturers of Vaccines
Figure Growth Hormones Picture
Table Major Manufacturers of Growth Hormones
Figure Purified Proteins Picture
Table Major Manufacturers of Purified Proteins
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Bio-pharma
Figure Global Consumption Volume Market Share of Bio-pharma by Application in 2015
Figure Metabolic Disorders Examples
Table Major Consumers of Metabolic Disorders
Figure Oncology Examples
Table Major Consumers of Oncology
Figure Neurological Disorders Examples
Table Major Consumers of Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Major Consumers of Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Major Consumers of Inflammatory and Infectious Diseases
Figure Others Examples
Table Major Consumers of Others
Figure Market Share of Bio-pharma by Regions
Figure North America Bio-pharma Market Size (2011-2021)
Figure China Bio-pharma Market Size (2011-2021)
Figure Europe Bio-pharma Market Size (2011-2021)
Figure Southeast Asia Bio-pharma Market Size (2011-2021)
Figure Japan Bio-pharma Market Size (2011-2021)
Figure India Bio-pharma Market Size (2011-2021)
Table Bio-pharma Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bio-pharma in 2015
Figure Manufacturing Process Analysis of Bio-pharma
Figure Industry Chain Structure of Bio-pharma
Table Capacity (K Units) and Commercial Production Date of Global Bio-pharma Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Bio-pharma Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Bio-pharma Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Bio-pharma Major Manufacturers in 2015
Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Bio-pharma 2011-2016
Figure Global 2011-2016E Bio-pharma Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Bio-pharma Market Size (Value) and Growth Rate
Table 2011-2016E Global Bio-pharma Capacity and Growth Rate
Table 2015 Global Bio-pharma Capacity List (Company Segment)
Table 2011-2016E Global Bio-pharma Sales and Growth Rate
Table 2015 Global Bio-pharma Sales List (Company Segment)
Table 2011-2016E Global Bio-pharma Sales Price
Table 2015 Global Bio-pharma Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Bio-pharma 2011-2016 (K Units)
Figure North America 2011-2016E Bio-pharma Sales Price (USD/Unit)
Figure North America 2015 Bio-pharma Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Bio-pharma 2011-2016 (K Units)
Figure China 2011-2016E Bio-pharma Sales Price (USD/Unit)
Figure China 2015 Bio-pharma Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Bio-pharma 2011-2016 (K Units)
Figure Europe 2011-2016E Bio-pharma Sales Price (USD/Unit)
Figure Europe 2015 Bio-pharma Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Bio-pharma 2011-2016 (K Units)
Figure Southeast Asia 2011-2016E Bio-pharma Sales Price (USD/Unit)
Figure Southeast Asia 2015 Bio-pharma Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Bio-pharma 2011-2016 (K Units)
Figure Japan 2011-2016E Bio-pharma Sales Price (USD/Unit)
Figure Japan 2015 Bio-pharma Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Bio-pharma 2011-2016 (K Units)
Figure India 2011-2016E Bio-pharma Sales Price (USD/Unit)
Figure India 2015 Bio-pharma Sales Market Share
Table Global 2011-2016E Bio-pharma Sales by Type
Table Different Types Bio-pharma Product Interview Price
Table Global 2011-2016E Bio-pharma Sales by Application
Table Different Application Bio-pharma Product Interview Price
Table Pfizer Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Pfizer Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer 2015 Bio-pharma Business Region Distribution
Table F. Hoffmann-La Roche AG Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 F. Hoffmann-La Roche AG Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 F. Hoffmann-La Roche AG 2015 Bio-pharma Business Region Distribution
Table Johnson & Johnson Services Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Johnson & Johnson Services Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Johnson & Johnson Services 2015 Bio-pharma Business Region Distribution
Table Sanofi, Amgen Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Sanofi, Amgen Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi, Amgen 2015 Bio-pharma Business Region Distribution
Table AbbVie Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 AbbVie Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 AbbVie 2015 Bio-pharma Business Region Distribution
Table Merck & Co., Inc Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Merck & Co., Inc Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Merck & Co., Inc 2015 Bio-pharma Business Region Distribution
Table Biogen Idec Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Biogen Idec Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Biogen Idec 2015 Bio-pharma Business Region Distribution
Table Bayer AG Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Bayer AG Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Bayer AG 2015 Bio-pharma Business Region Distribution
Table Eli Lilly and Company Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Eli Lilly and Company Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly and Company 2015 Bio-pharma Business Region Distribution
Table Novartis AG GlaxoSmithKline Plc Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Novartis AG GlaxoSmithKline Plc 2015 Bio-pharma Business Region Distribution
Table Bristol-Myers Squibb Company Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Bristol-Myers Squibb Company Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Bristol-Myers Squibb Company 2015 Bio-pharma Business Region Distribution
Table AstraZeneca PLC Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 AstraZeneca PLC Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 AstraZeneca PLC 2015 Bio-pharma Business Region Distribution
Table Abbott Laboratories Information List
Table Type I Bio-pharma Overview
Table Type II Bio-pharma Overview
Table Type III Bio-pharma Overview
Table 2015 Abbott Laboratories Bio-pharma Revenue, Sales, Ex-factory Price
Figure 2015 Abbott Laboratories 2015 Bio-pharma Business Region Distribution
Figure Global 2016-2021 Bio-pharma Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Bio-pharma Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Bio-pharma Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Bio-pharma Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Bio-pharma Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Bio-pharma Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Bio-pharma Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Bio-pharma Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Bio-pharma Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Units) of Bio-pharma by Types 2016-2021
Table Global Consumption Volume (K Units) of Bio-pharma by Applications 2016-2021
Table Traders or Distributors with Contact Information of Bio-pharma by Regions
Table Part of Interviewees Record List